MS clinic thrives by making regular care a ‘loss leader’June 2, 2018Multiple SclerosisBusiness of Medicine
New guidelines for gadolinium-based contrast agents take conservative stanceJune 1, 2018Multiple Sclerosis
VIDEO: PML prevention is possible, even when treating patients with aggressive MSJune 1, 2018Multiple Sclerosis
Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatmentJune 1, 2018Multiple Sclerosis
Ocrelizumab safety update: Encouraging rates of serious infection, malignancyMay 18, 2018Multiple Sclerosis
FDA expands fingolimod's indications to treat relapsing MS in pediatric patientsMay 11, 2018Multiple Sclerosis
